News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Onyx Pharmaceuticals, Inc. (JOBS) Updates Cancer Drug Trials
February 13, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Biotechnology company Onyx Pharmaceuticals Inc. said Thursday it plans to provide an update on Nexavar, a cancer drug for which the company is seeking additional Food and Drug Administration approval.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Bayer
MORE ON THIS TOPIC
FDA
US government launches AI-driven programs to overhaul clinical trials
October 1, 2026
·
4 min read
·
Gabrielle Masson
Insights
The race for access: How the FAIR Act could reclaim U.S. biotech leadership
October 1, 2026
·
1 min read
·
Jennifer C. Smith-Parker
FDA
Atara, Pierre Fabre resubmit twice-rebuffed cell therapy after FDA flips again
September 30, 2026
·
3 min read
·
Heather McKenzie
FDA
AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll
September 30, 2026
·
1 min read
·
Jef Akst
